EXPIRED
Department of Health and Human Services
Participating Organizations
National
Institutes of Health (NIH), (http://www.nih.gov)
Components of
Participating Organizations
National
Institute of Neurological Disorders and Stroke (NINDS), (http://www.ninds.nih.gov/)
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov)
National Institute of Environmental Health Sciences (NIEHS),
(http://www.niehs.nih.gov)
National Institute on Aging (NIA), (http://www.nia.nih.gov)
Title: International Neuroscience Fellowship (F05)
Announcement
Type
New
Update: The following update relating to this announcement has been issued:
Key Dates
Release Date: March 9, 2006
Letters of Intent
Receipt Date(s): July 14, 2006, 2007, 2008
Application Receipt Date(s): August 14, 2006, 2007, 2008
Review
Date(s): October 2006,
2007, 2008
Council Review
Date(s): February 2007,
2008, 2009
Earliest
Anticipated Start Date: April 1, 2007, 2008, 2009
Expiration Date: August 15, 2008
Due Dates for E.O. 12372
Not
Applicable
Additional
Overview Content
Executive Summary
Table of Contents
Part
I Overview Information
Part
II Full Text of Announcement
Section
I. Funding Opportunity Description
1. Training and Research
Objectives
Section
II. Award Information
1. Mechanism(s) of Support
2. Funds Available
Section
III. Eligibility Information
1. Eligible Applicants
A. Eligible Institutions
B. Eligible Individuals
2. Cost Sharing or Matching
3. Other - Special Eligibility Criteria
Section
IV. Application and Submission Information
1. Address to Request Application
Information
2. Content and Form of Application
Submission
3. Submission Dates and Times
A. Receipt and Review and
Anticipated Start Dates
1. Letter of
Intent
B. Sending an Application to
the NIH
C. Application Processing
4. Intergovernmental Review
5. Funding Restrictions
6. Other Submission Requirements
Section
V. Application Review Information
1. Criteria
2. Review and Selection Process
A. Additional Review Criteria
B. Additional Review
Considerations
C. Sharing Research Data
D. Sharing Research Resources
3. Anticipated Announcement and Award
Dates
Section
VI. Award Administration Information
1. Award Notices
2. Administrative and National Policy
Requirements
3. Reporting
Section
VII. Agency Contact(s)
1. Scientific/Research Contact(s)
2. Peer Review Contact(s)
3. Financial/ Grants Management Contact(s)
Section
VIII. Other Information - Required Federal Citations
Part II - Full Text of Announcement
Section I. Funding Opportunity Description
1. Training and Research Objectives
Specific Research Interests of Participating Institutes:
Applicants can obtain information and research interests for each of the participating institutes listed at the beginning of this announcement at their web sites, or by contacting the institute program contact listed in this announcement (see Section VII. Agency Contacts).
See Section
VIII, Other Information - Required Federal Citations, for policies related
to this announcement.
Section II. Award Information
1. Mechanism(s) of Support
This funding opportunity will use the international research fellowship (F05) award mechanism.
As an applicant, you and your U.S. sponsor are jointly responsible for planning, directing, and executing the proposed project.
This program is designed to provide training and research opportunities for qualified, non-immigrant foreign scientists who are currently residing outside the U.S. The applicant is required to have a doctoral degree (or its equivalent) in one of the biomedical or behavioral sciences. The proposed research training must be within the broad scope of biomedical, behavioral, or clinical research as it relates to neuroscience, and must offer an opportunity to enhance the fellow's understanding of the health-related sciences and to extend his or her potential for a productive independent research career.
This funding opportunity uses the non-modular budget format described in the PHS 416-1 application instructions (see http://grants.nih.gov/grants/funding/416/phs416.htm).
Duration of Support: Individuals may receive a minimum of one year and up to two years of support for research training at a basic or clinical research facility within the U.S. (referred to as the U.S. sponsoring institution).
2. Funds Available
The number of awards that will be funded under this program announcement is contingent upon the quality of the applications received, the availability of funds, and the program priorities of the participating NIH institutes.
Stipends: This fellowship award provides a stipend to the fellow to help defray living expenses during the research training experience at the U.S. sponsoring institution. The awards are not provided as a condition of employment with either the Federal government or the U.S. sponsoring institution.
Fellowship awardees are required to pursue their research training on a full-time basis, normally defined as 40 hours per week, or as specified by the sponsoring institution in accordance with its own policies, to the training program. Research clinicians must also devote full-time to their proposed research training and must restrict clinical duties to activities that are directly related to their research training experience. This fellowship may not be used to support studies leading to a N.D., D.C., M.D., D.O., D.D.S., D.V.M., or other similar health-professional degrees, and it may not be used to support the clinical years of residency training.
The fellowship awardee's requested stipend must be in accordance with the salary structure of the U.S. sponsoring institution and consistent with the level of effort.
While the INF is not one of the Ruth L. Kirschstein National Research Service Award (NRSA) fellowships, the amount of the award will be determined by the NRSA postdoctoral stipend guidelines. The maximum NRSA stipend level is based on full years of relevant postdoctoral experience. Relevant experience may include research (including research in industry), teaching, internship, residency, clinical duties, or other time spent in full-time studies in a health-related field beyond that of the qualifying doctoral degree. The NRSA stipend schedule is updated nearly every year, and applicants are advised to check the current stipend schedule at http://grants.nih.gov/training/nrsa.htm. For fellows sponsored by domestic non-federal institutions, the stipend will be paid through the sponsoring institution. For fellows sponsored by Federal institutions, the monthly stipend payment will be deposited in the fellow s U.S. bank account or paid directly to the fellow by a U.S. Department of Treasury check.
Tuition and Fees: The NIH awarding institute will reimburse the combined cost of tuition, fees and applicable health insurance according to the policies and rates at the time of award. The following rate is currently applied: 100 percent of all costs up to $3,000 and 60 percent of costs above $3,000. Costs associated with tuition and fees are allowable only if they are required for specific courses in support of the research training experience of the fellow at the U.S. sponsoring institution. A full description of the current tuition policy is contained within the NRSA section of the Grants Policy Statement at http://grants.nih.gov/grants/policy/policy.htm.
Health Insurance: Self-only health insurance (available to fellows without families) or family health insurance (available to fellows with families) is an allowable cost for fellows at the U.S. sponsoring institution only if such self or family health insurance is required of all persons in a similar training status regardless of the source of support. Health insurance for fellows who are eligible for this coverage is included in the calculation of the combined tuition, fees, and health insurance.
Institutional Allowance at the U.S. Sponsoring Institution: The NIH awarding institutes will provide an institutional allowance of up to $7,000 per 12-month period to nonprofit nonfederal U.S. sponsoring institutions or up to $6,000 per 12 month period to for-profit or Federal laboratories to help defray such awardee's expenses as research supplies, equipment, books, travel to scientific meetings and/or to the fellow’s home institution. This allowance is intended to cover the research training-related expenses for the individual awardee. The allowance for traveling back to the foreign institution may include a single economy or coach round-trip travel fare. No travel allowance is provided for the awardee’s dependents. U.S. flag air carriers must be used to the maximum extent possible when commercial air transportation is available for travel between the U.S. and the foreign country. For fellows at for-profit institutions, the institutional allowance will be paid to the institution for disbursement to the fellow. For fellows at Federal laboratories, the allowance will be disbursed from the NIH awarding institute. The allowance is not available until the fellow officially activates the award.
Other Training Costs: Additional funds may be requested by the U.S. sponsoring institution for accommodations for fellows who are disabled, as defined by the Americans with Disabilities Act. The funds requested for costs of this nature must be reasonable in relationship to the total dollars awarded under the fellowship and must be directly related to the approved research training experience. Such additional funds shall be provided only for circumstances that are fully justified and explained by the U.S. sponsoring institution.
Facilities and Administrative (F&A) Costs: F&A costs are not allowed for the U.S. sponsoring institution.
Supplementation of Stipends, Compensation, and Other Income
The U.S. sponsoring institution is allowed to provide funds to the fellow in addition to the stipend and institutional allowance paid by the NIH awarding institute while the fellow is training at the U.S. institution. Such additional amounts may be in the form of an augmented stipend (supplementation) or in the form of compensation, provided the conditions described below are met. Under no circumstances may the conditions of stipend supplementation interfere with, detract from, or prolong the fellow’s approved INF research training program.
Stipend Supplementation: Supplementation, or additional support to offset the cost of living, may be provided by the U.S. sponsoring institution. Supplementation does not require additional effort from the fellow. DHHS funds may not be used for supplementation under any circumstances. Additionally, no funds from other Federal agencies may be used for supplementation unless specifically authorized by both the NIH and the other Federal agency.
Compensation: The U.S. sponsoring institution may not provide funds in addition to the stipend in the form of compensation, such as salary or tuition remission, for services provided, such as teaching. The fellow should spend 100 percent effort on activities related to this research training award and should not be required to perform additional paid services while at the U.S. sponsoring institution.
The complete policy for stipend supplementation and compensation is located in the NIH Grants Policy Statement at: http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part10.htm.
Section III. Eligibility Information
1. Eligible Applicants
1.A.
Eligible Institutions
You (as the sponsoring
institution) may submit (an) application(s) if your organization has any of the
following characteristics:
Please note that National Institutes of Health intramural laboratories are not included as eligible agencies of the Federal Government. The sponsoring institution must be a basic or clinical research facility in the U. S.
1.B. Eligible Individuals
Any
individual with the skills, knowledge, and resources necessary to carry out the
proposed research training is invited to work with his or her U.S. sponsor and sponsoring institution to develop an application for support. Women, individuals
from underrepresented racial and ethnic groups as well as individuals with
disabilities and individuals from disadvantaged backgrounds are always
encouraged to apply for NIH programs.
Degree Requirements: Applicants to the INF must have earned a doctoral degree (M.D., Ph.D., D.V.M., D.D.S., D.O., O.D., D.P.M., Sc.D., Eng.D., D.N.S., Pharm.D., D.S.W., Psy.D. or equivalent) from an accredited U.S. or foreign institution at the time their application is submitted in response to this program announcement. The applicant must provide a photocopy of his or her diploma, and a certified English translation if the original document is not in English.
Citizenship: Non-immigrant foreign scientists who are not currently residing in the U.S. are eligible for this award. U.S. citizens, non-citizen nationals, or persons with U.S. permanent resident status are not eligible for this award. Individuals in the latter three categories should consult the NIH website for descriptions of other fellowship and career development awards for which they may be eligible (http://www.training.nih.gov/).
Preference will be given to applicants from low- to middle-income countries. For the purpose of this program announcement, a low- to middle-income country is defined as a country that has a Gross National Income per capita (GNI per capita) below $9,000, according to the World Bank classification system (refer to the GNI per capita ranking in the left-hand column labeled Atlas Methodology at http://www.worldbank.org/data/databytopic/GNIPC.pdf. Do NOT refer to the right-hand column headed Purchasing Power Parity).
VISA Requirements: Foreign nationals who apply for this fellowship must have a visa that permits training or employment in the U.S. at the time that an award is made.
It will be the responsibility of the candidate’s U.S. sponsoring institution to determine and document that the candidate’s visa will allow him or her to remain in the U.S. long enough to complete the proposed research training program.
Language Requirement: The applicant must be proficient in English.
2. Cost Sharing or Matching
Cost sharing is not required.
The most current
Grants Policy Statement can be found at: http://grants.nih.gov/grants/policy/nihgps_2003/nihgps_Part2.htm#matching_or_cost_sharing
3. Other-Special
Eligibility Criteria
Sponsor: Before
submitting a fellowship application, the applicant must identify a U.S. sponsoring institution and an individual who will serve as the sponsor (also called
mentor or supervisor). The sponsor must be affiliated with the U.S. sponsoring institution and be funded to conduct independent research (e.g., Principal
Investigator on an NIH R01 grant) in an area that is appropriate for the
proposed research training. The sponsor must be committed to the training and
must directly supervise the fellow's research during the entire period of the
fellowship. The sponsor must document the availability of sufficient current research
support and facilities for high-quality research training at the U.S. sponsoring institution.
Sponsoring Institution: The sponsoring institution must have staff and facilities available on site to provide a suitable environment for performing high-quality research training in the proposed research area.
Requirements for the Foreign Institution: The fellowship will be awarded to the U.S. sponsoring institution only. However, no application will be accepted without an accompanying endorsement letter from the Foreign Institution to which the applicant plans to return. In this letter, the Foreign Institution must assure that the applicant has a guaranteed appointment at the institution upon his or her return. The letter should contain the following information: 1) the title and description of the applicant’s appointment at this institution; 2) the guaranteed duration of the appointment; and 3) a description of the research facility and environment at this institution, including facilities and equipment available to the applicant. This letter must be signed by the appropriate institutional business and academic officials (such as a university dean who is responsible for the applicant's appointment) and included in the same package with the copies of the completed application.
Section IV. Application and Submission Information
1. Address to Request
Application Information
The
PHS 416-1 (rev. 10/05) fellowship application instructions are available at http://grants.nih.gov/grants/funding/416/phs416.htm#forms in an interactive format. Applicants must use the currently approved version of
the PHS 416-1. Please note the PHS 416-1 form is used for several different
types of fellowship applications. Therefore, not all statements in the form may
be applicable to the INF. For further assistance contact GrantsInfo, Telephone
(301) 710-0267, Email: [email protected].
Telecommunications for the hearing impaired: TTY
301-451-5936.
2. Content and Form of
Application Submission
Applications must
be prepared using the most current PHS 416-1 grant application instructions
and forms. Applications must have a D&B Data Universal Numbering System
(DUNS) number as the universal identifier when applying for Federal grants or
cooperative agreements. The D&B number can be obtained by calling (866)
705-5711 or through the web site at http://www.dnb.com/us/.
The D&B number should be entered on line 13b of the face page of the PHS 416-1 form.
The title and number of this program announcement must
be typed on line 3 of the face page of the application form and the YES box
must be checked.
3. Submission Dates and
Times
See Section IV.3.A for details.
3.A.
Receipt, Review and Anticipated Start Dates
Letters
of Intent Receipt Date(s): July 14, 2006, 2007, 2008
Application Receipt Date(s): August 14, 2006, 2007, 2008
Review
Date(s): October 2006,
2007, 2008
Council Review
Date(s): February 2007,
2008, 2009
Earliest
Anticipated Start Date: April 1, 2007, 2008, 2009
3.A.1.
Letter of Intent
Prospective
applicants are asked to submit a letter of intent that includes the following
information:
Although
a letter of intent is not required and is not binding, and does not enter into
the review of a subsequent application, the information that it contains allows
NIH staff to estimate the potential review workload and plan the review.
The letter of intent is to be sent by the date listed
at the beginning of this document.
The letter of
intent should be sent to:
Stacey D. Chambers
Program Analyst
Office of International Activities
National Institute of Neurological Disorders and Stroke
6001 Executive Boulevard
Neuroscience Center, Room 2185
Bethesda, MD 20892-9523
Telephone: (301) 496-0690
FAX: (301) 402-1501
Email: [email protected]
3.B.
Sending an Application to the NIH
Applications must
be prepared using the training grant application forms found in the PHS
416-1 instructions for preparing a fellowship application. Submit a signed, typewritten
original of the application, including the checklist, sealed reference letters, and all
other required materials) and two exact, clear, single-sided photocopies of the
signed application, in one package to:
Center for
Scientific Review
National Institutes of Health
6701 Rockledge Drive, Room 1040, MSC 7710
Bethesda, MD 20892-7710 (U.S. Postal Service Express
or regular mail)
Bethesda, MD 20817 (for express/courier service;
non-USPS service)
Applications responding to this program announcement must include at least three sealed letter of reference following the instructions and using the CDA Reference Guidelines Format Page found in Section III of the PHS 398 application attached to the face page of the original application. Applications submitted without the required number of reference letters will be considered incomplete and will be returned without review.
Personal deliveries of applications are no longer permitted (see http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-040.html).
3.C. Application Processing
Applications must
be received on or before the application
receipt/submission date(s) described above (Section IV.3.A.). If an application is
received after that date, it will be returned to the applicant without review.
Upon receipt
applications will be evaluated for completeness by CSR. Incomplete applications
will not be reviewed.
The NIH will not
accept any application in response to this funding opportunity that is
essentially the same as one currently pending initial merit review unless the
applicant withdraws the pending application. The NIH will not accept any
application that is essentially the same as one already reviewed. This does not
preclude the submission of a substantial revision of an application already
reviewed, but such application must include an Introduction addressing the
previous critique.
Although there is
no immediate acknowledgement of the receipt of an application, applicants are
generally notified of the review and funding assignment within eight (8) weeks.
4. Intergovernmental
Review
This
initiative is not subject to intergovernmental
review.
5.
Funding Restrictions
All NIH awards
are subject to the terms and conditions, cost principles, and other
considerations described in the NIH Grants Policy Statement. The Grants Policy Statement can be found at http://grants.nih.gov/grants/policy/policy.htm.
Concurrent
Awards: The INF may not be held concurrently with another U.S. federally sponsored fellowship or similar Federal award that provides a stipend/salary
or otherwise duplicates provisions of this award.
6. Other Submission Requirements
Applicants are advised to pay special attention to the following items in the PHS 416-1:
Section I - Applicant Information:
Section II Sponsor Information:
Instruction in the Responsible Conduct of Research Applications must include the candidate's plans for obtaining instruction in the responsible conduct of research, including the rationale, subject matter, appropriateness, format, frequency and duration of instruction. Although the NIH has not established specific curriculum or format requirements for this training, it is suggested that the following topics be covered: conflict of interest, data sharing, responsible authorship, policies for handling misconduct, policies regarding the use of human and animal subjects, and data management. Applications without plans for training in responsible conduct of research will be considered incomplete and may be returned without review. No award will be made if an application lacks this component.
Human Subjects Research If the proposed research involves human subjects, the applicant must be responsive to the instructions in the current version of the PHS 416-1. The adequacy of plans to include appropriate human subjects is included in the fellowship evaluation (see Additional Review Criteria below). Note that NIH defines children as individuals under 21 years of age. Consult the decision tree for the exemptions that apply: http://grants.nih.gov/grants/peer/tree_children_hs.pdf.
Care and Use of Vertebrate Animals in Research If vertebrate animals are to be used in the project, the applicant must be responsive to the instructions in the current version of the PHS 416-1. The adequacy of plans for the care and use of vertebrate animals is assessed as part of the fellowship evaluation.
Biohazards The investigator and the sponsoring institution are responsible for protecting the environment and research personnel from hazardous conditions. If materials or procedures are proposed that are potentially hazardous to research personnel and/or the environment, please describe the procedures to be taken in order to ensure adequate protection.
Additional Documents required for the Program
Letters of Reference (three required) and statements related to the potential of the applicant for a leadership position in research, academia or public health in his or her home country
Endorsement letter from the foreign institution indicating a guaranteed appointment following completion of the F05 program
Plan for Sharing Research Data
Not
applicable
Sharing Research Resources
NIH policy requires that grant awardee
recipients make unique research resources readily available for research
purposes to qualified individuals within the scientific community after
publication (NIH Grants Policy Statement http://grants.nih.gov/grants/policy/nihgps_2003/index.htm and http://grants.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part7.htm#_Toc54600131).
Investigators responding to this funding opportunity should include a plan for
sharing research resources addressing how unique research resources will be
shared or explain why sharing is not possible.
The adequacy of the resources sharing plan will be considered by Program staff of the funding organization when making recommendations about funding applications. The effectiveness of the resource sharing will be evaluated as part of the administrative review of each non-competing Grant Progress Report (PHS 2590, http://grants.nih.gov/grants/funding/2590/2590.htm). See Section VI.3. Reporting.
Section V. Application Review Information
1. Criteria
Only the review criteria described below will be considered
in the review process.
2. Review and Selection
Process
Applications
that are complete will be evaluated for scientific and technical merit by an
appropriate review group convened by NINDS in accordance with the review
criteria stated below.
As part of the
initial merit review, all applications will:
The following will be considered in making funding decisions:
The goal of the INF Program is to strengthen the human resource capital of neuroscience research in international institutions. Through this program announcement, investigators are expected to pursue independent and productive careers which stimulate research in the neurosciences on a global scale. The scientific review group will be asked to address each of the following criteria when assigning the overall score, weighting them as appropriate for each application.
Candidate
Sponsor and Training Environment at the U.S. Sponsoring Institution
Research and Training Proposal
2.A. Additional Review Criteria:
In addition to
the above criteria, the following items will continue to be considered in the
determination of scientific merit and the priority score:
Protection
of Human Subjects from Research Risk: The involvement of human subjects and protections from
research risk relating to their participation in the proposed research will be
assessed (see the Research Plan, Section E on Human Subjects in the PHS Form
398).
Inclusion
of Women, Minorities and Children in Research: The adequacy of plans to
include subjects from genders, all racial and ethnic groups (and subgroups),
and children as appropriate for the scientific goals of the research will be
assessed. Plans for the recruitment and retention of subjects will also be
evaluated (see the Research Plan, Section E on Human Subjects in the PHS Form
398).
Care
and Use of Vertebrate Animals in Research: If vertebrate animals are to
be used in the project, the five items described under Section F of the PHS
Form 398 research grant application instructions will be assessed.
Biohazards: If materials or procedures
are proposed that are potentially hazardous to research personnel and/or the
environment, determine if the proposed protection is adequate.
2.B.
Additional Review Considerations
Responsible Conduct of Research. Every INF fellow must
receive instruction in the responsible conduct of research (http://grants.nih.gov/grants/guide/notice-files/not92-236.html).
Applications must include the candidate's plans for obtaining instruction in
the responsible conduct of research, including the rationale, subject matter,
appropriateness, format, frequency and duration of instruction. The plan will
be discussed after the overall determination of merit, so that the review
panel's evaluation of the plan will not be a factor in the determination of the
priority score. The plan will be judged as acceptable or unacceptable. The
acceptability of the plan will be described in an administrative note of the
summary statement. Regardless of the priority score, an application with an
unacceptable plan will not be funded until the applicant provides a revised
acceptable plan. Staff in the NIH awarding institute will judge the
acceptability of the revised plan.
2.C. Sharing Research Data
Not
applicable
2.D. Sharing Research Resources
NIH policy requires that grant awardee recipients make unique research resources readily available for research purposes to qualified individuals within the scientific community after publication (See the NIH Grants Policy Statement http://grants.nih.gov/grants/policy/nihgps/part_ii_5.htm#availofrr and http://www.ott.nih.gov/policy/rt_guide_final.html). Investigators responding to this funding opportunity should include a sharing research resources plan addressing how unique research resources will be shared or explain why sharing is not possible.
The adequacy of the resources sharing plan will be considered by Program staff of the funding organization when making recommendations about funding applications. Program staff may negotiate modifications of the resource sharing plan with the principal investigator before recommending funding of an application. The final version of the resource sharing plan negotiated by both will become a condition of the award of the grant. The effectiveness of the resource sharing will be evaluated as part of the administrative review of each non-competing Grant Progress Report (PHS 2590). See Section VI.3. Reporting.
3.
Anticipated Announcement and Award Dates
Not
applicable
Section VI. Award Administration Information
1. Award Notices
After the peer
review of the application is completed, the applicant will be able to access
his or her Summary Statement (written critique) via the eRA Commons.
A formal notification in the form of a Notice of Research Fellowship
Award will be provided to the applicant
organization. This
notice signed by the grants management officer is the authorizing
document. Once all administrative and programmatic issues have been resolved, this notice will be sent
electronically to the designated U.S. Sponsoring institution’s business
official listed on the face page of the application or may be retrieved by the
institution through its NIH eRA Commons account.
Selection of an application for award is not an
authorization to begin performance. No funds may be disbursed until the fellow has started
training under the award and an Activation Notice (PHS 416-5) has been
submitted to the NIH. The fellow has up to six months from the fellowship
award issue date to activate the award.
2.
Administrative and National Policy Requirements
Fellowships
must be administered in accordance with the current fellowship section of the
Grants Policy Statement (http://grants.nih.gov/grants/policy/policy.htm),
and any terms and conditions specified on the Notice of Grant Award.
Leave Policies: In general, during the years of support at the U.S. sponsoring institution, fellows may receive a stipend during the normal periods of vacation and holidays observed by individuals in comparable training positions at the sponsoring institution. For the purpose of these awards, however, the period between the spring and fall semesters is considered to be an active time of research and research training and is not considered to be a vacation or holiday. Fellows may receive stipend for up to 15 calendar days of sick leave per year.
A period of terminal leave is not permitted and payment may not be made from fellowship funds for leave not taken. Fellows requiring periods of time away from their research training experience longer than specified here must seek approval from the NIH awarding institute for an unpaid leave of absence.
3.
Reporting
Activation
Notice: An awardee has up to six months from the issue date on the
Notice of Research Fellowship Award to activate the award using the Individual
Fellowship Activation Notice (PHS 416-5) available at http://grants.nih.gov/grants/forms.htm.
Under unusual circumstances, an NIH Institute may grant an extension of the
activation period upon receipt of a specific request from the fellow. Such a
request must be countersigned by the U.S. sponsor and an authorized
institutional official of the U.S. sponsoring institution.
Application for Continued Support and Progress Report: For a two year award, the awardees are required to submit the form PHS 416-9, Continuation of INF Award, annually (http://grants.nih.gov/grants/forms.htm) as required in the NIH Grants Policy Statement. The report is due two months before the beginning date of the next budget period and must include information related to the current year's progress as well as the plans for the coming year.
Termination Notice and Final Report: When support ends, the awardee must submit a Termination Notice (PHS 416-7) to the NIH within 30 days following termination. Forms may be found at http://grants.nih.gov/grants/funding/416/phs416-7.doc. The fellow and the U.S. sponsor are responsible for providing a final report, detailing the following information:
We encourage your inquiries concerning this funding
opportunity and welcome the opportunity to answer questions from potential applicants.
Inquiries may fall into three areas: scientific/research, peer review, and
financial or grants management issues:
1. Scientific/Research
Contacts:
Yuan
Liu, Ph.D.
Chief
Office of International Activities
National Institute of
Neurological Disorders and Stroke
6001 Executive Blvd.
Neuroscience Center, Room
2187
Bethesda, MD 20892-9523
Telephone: 301-496-0012
FAX: 301-402-1501
E-mail: [email protected]
David Shurtleff,
Ph.D.
Director
Division of Basic
Neuroscience & Behavioral Research
National Institute
on Drug Abuse
6001 Executive
Boulevard Rm 4282, MSC 9555
Bethesda,
MD 20892-9555
Telephone: 301-443-1887
FAX: 301-594-6043
E-mail: [email protected]
Michael C. Humble,
Ph.D.
Program
Administrator
Cellular, Organs and
Systems Pathobiology Branch
Division of
Extramural Research and Training
National Institute
of Environmental Health Sciences
111 T.W. Alexander
Drive, PO Box 12233, MD-EC-23
Research Triangle
Park, NC 27709
Telephone: 919-316-4621
FAX: 919-541-5064
E-mail: [email protected]
Andrew A. Monjan,
Ph.D., M.P.H.
Chief, Neurobiology
of Aging Branch
Neuroscience and
Neuropsychology of Aging Program
National Institute
on Aging
Gateway Building, suite 350
7201 Wisconsin
Avenue, MSC 9205
Bethesda,
MD 20892-9205
Telephone: (301)
496-9350
Email: [email protected]
2. Peer Review Contacts:
Chief,
Scientific Review Branch
National Institute of Neurological
Disorders and Stroke
Room 3201, MSC 9529
6001 Executive Boulevard
Bethesda, MD 20892-9529
(Rockville, MD 20852 for
express/courier service)
Telephone: (301) 496-9223
Fax: (301) 402-0182
E-mail: [email protected]
3. Financial or
Grants Management Contacts:
Christina
Zimmerman
Grants Management Specialist
National Institute of Neurological
Disorders and Stroke
Neuroscience Center, Room
3273
6001 Executive Blvd
Bethesda, MD 20892-9537
Telephone: 301-496-3107
Fax: 301-402-0219
Email: [email protected]
Section VIII. Other Information
Required Federal Citations
Use of Animals
in Research:
Recipients of PHS support for activities involving
live, vertebrate animals must comply with PHS Policy on Humane Care and Use of
Laboratory Animals (http://grants.nih.gov/grants/olaw/references/PHSPolicyLabAnimals.pdf)
as mandated by the Health Research Extension Act of 1985 (http://grants.nih.gov/grants/olaw/references/hrea1985.htm),
and the USDA Animal Welfare Regulations (http://www.nal.usda.gov/awic/legislat/usdaleg1.htm)
as applicable.
Human Subjects Protection:
Federal regulations (45CFR46) require that
applications and proposals involving human subjects must be evaluated with
reference to the risks to the subjects, the adequacy of protection against
these risks, the potential benefits of the research to the subjects and others,
and the importance of the knowledge gained or to be gained (http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm).
Data and Safety Monitoring Plan:
Data and safety monitoring is required for all types
of clinical trials, including physiologic toxicity and dose-finding studies
(Phase I); efficacy studies (Phase II); efficacy, effectiveness and comparative
trials (Phase III). Monitoring should be commensurate with risk. The
establishment of data and safety monitoring boards (DSMBs) is required for
multi-site clinical trials involving interventions that entail potential risks
to the participants (NIH Policy for Data and Safety Monitoring, NIH Guide for
Grants and Contracts, http://grants.nih.gov/grants/guide/notice-files/not98-084.html).
Sharing Research Data:
Investigators submitting an NIH application seeking
$500,000 or more in direct costs in any single year are expected to include a
plan for data sharing or state why this is not possible (http://grants.nih.gov/grants/policy/data_sharing).
Investigators should seek guidance from their institutions
on issues related to institutional policies and local IRB rules, as well as
local, State and Federal laws and regulations, including the Privacy Rule.
Reviewers will consider the data sharing plan but will not factor the plan into
the determination of scientific merit or the priority score.
Access to Research Data through the Freedom of
Information Act:
The Office of Management and Budget (OMB) Circular
A-110 has been revised to provide access to research data through the Freedom
of Information Act (FOIA) under some circumstances. Data that are (1) first
produced in a project that is supported in whole or in part with Federal funds
and (2) cited publicly and officially by a Federal agency in support of an
action that has the force and effect of law (i.e., a regulation) may be
accessed through FOIA. It is important for applicants to understand the basic
scope of this amendment. NIH has provided guidance at http://grants.nih.gov/grants/policy/a110/a110_guidance_dec1999.htm.
Applicants may wish to place data collected under this funding opportunity in a
public archive, which can provide protections for the data and manage the
distribution for an indefinite period of time. If so, the application should
include a description of the archiving plan in the study design and include
information about this in the budget justification section of the application.
In addition, applicants should think about how to structure informed consent
statements and other human subjects procedures given the potential for wider
use of data collected under this award.
Sharing of Model Organisms:
NIH is committed to support efforts that encourage
sharing of important research resources including the sharing of model
organisms for biomedical research (see http://grants.nih.gov/grants/policy/model_organism/index.htm).
At the same time the NIH recognizes the rights of grantees and contractors to
elect and retain title to subject inventions developed with Federal funding
pursuant to the Bayh Dole Act (see the NIH Grants Policy Statement http://grants.nih.gov/grants/policy/nihgps_2003/index.htm).
All investigators submitting an NIH application or contract proposal, beginning
with the October 1, 2004 receipt date, are expected to include in the
application/proposal a description of a specific plan for sharing and
distributing unique model organism research resources generated using NIH
funding or state why such sharing is restricted or not possible. This will
permit other researchers to benefit from the resources developed with public
funding. The inclusion of a model organism sharing plan is not subject to a
cost threshold in any year and is expected to be included in all applications
where the development of model organisms is anticipated.
Inclusion of Women And Minorities in Clinical
Research:
It is the policy of the NIH that women and members of
minority groups and their sub-populations must be included in all NIH-supported
clinical research projects unless a clear and compelling justification is
provided indicating that inclusion is inappropriate with respect to the health
of the subjects or the purpose of the research. This policy results from the
NIH Revitalization Act of 1993 (Section 492B of Public Law 103-43). All
investigators proposing clinical research should read the "NIH Guidelines
for Inclusion of Women and Minorities as Subjects in Clinical Research (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-001.html);
a complete copy of the updated Guidelines is available at http://grants.nih.gov/grants/funding/women_min/guidelines_amended_10_2001.htm.
The amended policy incorporates: the use of an NIH definition of clinical
research; updated racial and ethnic categories in compliance with the new OMB
standards; clarification of language governing NIH-defined Phase III clinical
trials consistent with the SF424 (R&R); and updated roles and
responsibilities of NIH staff and the extramural community. The policy
continues to require for all NIH-defined Phase III clinical trials that: a) all
applications or proposals and/or protocols must provide a description of plans
to conduct analyses, as appropriate, to address differences by sex/gender
and/or racial/ethnic groups, including subgroups if applicable; and b)
investigators must report annual accrual and progress in conducting analyses,
as appropriate, by sex/gender and/or racial/ethnic group differences.
Inclusion of Children as Participants in Clinical
Research:
The NIH maintains a policy that children (i.e.,
individuals under the age of 21) must be included in all clinical research,
conducted or supported by the NIH, unless there are scientific and ethical
reasons not to include them.
All investigators proposing research involving human
subjects should read the "NIH Policy and Guidelines" on the inclusion
of children as participants in research involving human subjects (http://grants.nih.gov/grants/funding/children/children.htm).
Required Education on the Protection of Human
Subject Participants:
NIH policy requires education on the protection of
human subject participants for all investigators submitting NIH applications
for research involving human subjects and individuals designated as key
personnel. The policy is available at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-039.html.
Human Embryonic Stem Cells (hESC):
Criteria for federal funding of research on hESCs can
be found at http://stemcells.nih.gov/index.asp and at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-005.html.
Only research using hESC lines that are registered in the NIH Human Embryonic
Stem Cell Registry will be eligible for Federal funding (http://escr.nih.gov). It is the responsibility
of the applicant to provide in the project description and elsewhere in the
application as appropriate, the official NIH identifier(s) for the hESC
line(s)to be used in the proposed research. Applications that do not provide
this information will be returned without review.
NIH Public Access Policy:
NIH-funded investigators are requested to submit to
the NIH manuscript submission (NIHMS) system (http://www.nihms.nih.gov)
at PubMed Central (PMC) an electronic version of the author's final manuscript
upon acceptance for publication, resulting from research supported in whole or
in part with direct costs from NIH. The author's final manuscript is defined as
the final version accepted for journal publication, and includes all
modifications from the publishing peer review process.
NIH is requesting that authors submit manuscripts
resulting from 1) currently funded NIH research projects or 2) previously
supported NIH research projects if they are accepted for publication on or
after May 2, 2005. The NIH Public Access Policy applies to all research grant
and career development award mechanisms, cooperative agreements, contracts,
Institutional and Individual Ruth L. Kirschstein National Research Service
Awards, as well as NIH intramural research studies. The Policy applies to
peer-reviewed, original research publications that have been supported in whole
or in part with direct costs from NIH, but it does not apply to book chapters,
editorials, reviews, or conference proceedings. Publications resulting from
non-NIH-supported research projects should not be submitted.
For more information about the Policy or the
submission process please visit the NIH Public Access Policy Web site at http://PublicAccess.nih.gov/ and
view the Policy or other Resources and Tools including the Authors' Manual (http://publicaccess.nih.gov/publicaccess_manual.htm).
Standards for Privacy of Individually Identifiable
Health Information:
The Department of Health and Human Services (DHHS)
issued final modification to the "Standards for Privacy of Individually
Identifiable Health Information", the "Privacy Rule", on August 14, 2002. The Privacy Rule is a federal regulation under the Health Insurance
Portability and Accountability Act (HIPAA) of 1996 that governs the protection
of individually identifiable health information, and is administered and
enforced by the DHHS Office for Civil Rights (OCR).
Decisions about applicability and implementation of
the Privacy Rule reside with the researcher and his/her institution. The OCR
Website (http://www.hhs.gov/ocr/)
provides information on the Privacy Rule, including a complete Regulation Text
and a set of decision tools on "Am I a covered entity?" Information
on the impact of the HIPAA Privacy Rule on NIH processes involving the review,
funding, and progress monitoring of grants, cooperative agreements, and
research contracts can be found at http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-025.html.
URLs in NIH Grant Applications or Appendices:
All applications and proposals for NIH funding must be
self-contained within specified page limitations. Unless otherwise specified in
an NIH solicitation, Internet addresses (URLs) should not be used to provide
information necessary to the review because reviewers are under no obligation
to view the Internet sites. Furthermore, we caution reviewers that their
anonymity may be compromised when they directly access an Internet site.
Healthy People 2010:
The Public Health Service (PHS) is committed to
achieving the health promotion and disease prevention objectives of
"Healthy People 2010," a PHS-led national activity for setting
priority areas. This PA is related to one or more of the priority areas.
Potential applicants may obtain a copy of "Healthy People 2010" at http://www.health.gov/healthypeople.
Authority and Regulations:
This program is described in the Catalog of
Federal Domestic Assistance at http://www.cfda.gov/ and is not subject to the intergovernmental review requirements of Executive
Order 12372 or Health Systems Agency review. Awards are made under the
authorization of Section 307 of the Public Health Service Act (42 USC 242l) and
under Federal Regulations 42 CFR 63a and 45 CFR Parts 74 and 92. All awards are
subject to the terms and conditions, cost principles, and other considerations
described in the NIH Grants Policy Statement. The NIH Grants Policy
Statement can be found at http://grants.nih.gov/grants/policy/policy.htm.
The PHS strongly encourages all grant recipients to
provide a smoke-free workplace and discourage the use of all tobacco products.
In addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits
smoking in certain facilities (or in some cases, any portion of a facility) in
which regular or routine education, library, day care, health care, or early
childhood development services are provided to children. This is consistent
with the PHS mission to protect and advance the physical and mental health of
the American people.
Loan Repayment Programs:
NIH encourages applications for educational loan repayment
from qualified health professionals who have made a commitment to pursue a
research career involving clinical, pediatric, contraception, infertility, and
health disparities related areas. The LRP is an important component of NIH's
efforts to recruit and retain the next generation of researchers by providing
the means for developing a research career unfettered by the burden of student
loan debt. Note that an NIH grant is not required for eligibility and
concurrent career award and LRP applications are encouraged. The periods of
career award and LRP award may overlap providing the LRP recipient with the
required commitment of time and effort, as LRP awardees must commit at least
50% of their time (at least 20 hours per week based on a 40 hour week) for two
years to the research. For further information, please see: http://www.lrp.nih.gov.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
| ||||||
Department of Health and Human Services (HHS) |
||||||
NIH... Turning Discovery Into Health® |